3 assets in Cholelithiasis

Therapeutic assets addressing Cholelithiasis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Gardasil 9 Vaccine Cholelithiasis	Eunice Dube	P4	BB (65)
Hepatitis B Virus Vaccine Cholelithiasis	Eunice Dube	P4	BB (65)
Ketorolac Cholelithiasis	Hamilton Health Sciences Corporation	P3	B (63)